US Patent Issued to Takeda Pharmaceutical on Aug. 12 for "Heterocyclic compound" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,770, issued on Aug. 12, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Heterocyclic compound" was invented by Masahiro Ito (Kanagawa, Japan), Hideyuki Sugiyama (Kanagawa, Japan), Takeshi Yamamoto (Kanagawa, Japan), Keiko Kakegawa (Kanagawa, Japan), Jinxing Li (Kanagawa, Japan), Junsi Wang (Kanagawa, Japan), Takahito Kasahara (Kanagawa, Japan) and Masato Yoshikawa (Kanagawa, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a heterocyclic compound having a HDAC6 inhibitory action, which is useful for the treatment of central nervous system diseases including neurodegenerative diseases, and the like, ...